Back

The prognosis evaluation of guideline-directed medical therapy for type 2 acute myocardial infarction patients with acute respiratory failure

1 September 2024 (18:00 - 18:50)
Organised by: Logo
Congress Presentation Part of: Acute heart failure and cardiogenic shock in acute coronary syndromes Pharmacotherapy ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Professor Kang-Yin Chen

2nd Hospital of Tianjin Medical University, Tianjin (China)

6 More presentations in this session

Presentation thumbnail
VA-ECMO-related complications seem not causally related to mortality in patients with acute myocardial infarction complicated by cardiogenic shock
Doctor T. Thevathasan (Berlin, DE)
Abstract Slides Video
Presentation thumbnail
STEMI SHOCK outcomes with SCAI classification
Professor J. French (Sydney, AU)
Abstract Slides Video
Presentation thumbnail
Association of culprit lesions with in-hospital mortality in patients with acute coronary syndrome complicated by cardiogenic Shock
Doctor S. Matsushita (Kurashiki, JP)
Abstract Slides Video
Presentation thumbnail
Do DAN-GER-SHOCK eligible patients benefit from VA-ECMO treatment in infarct-related cardiogenic shock ? Results of an individual patient data meta-analysis.
Professor U. Zeymer (Ludwigshafen, DE)
Abstract Slides Video
Presentation thumbnail
Impact of inhaled nitric oxide therapy in patients with cardiogenic shock treated with veno-arterial extracorporeal membrane oxygenation combined with Impella
Doctor M. Ueno (Osaka, JP) Doctor N. Yamada (Osaka, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Acute heart failure and cardiogenic shock in acute coronary syndromes

The Event

Event poster

ESC Congress 2024

1 September 2024 18:00 CET
You may be interested in
thumbnail
Congress Presentation
Antiplatelet can improve the short-term prognosis of type 2 myocardial infarction caused by acute respiratory failure
thumbnail
Congress Session
Improving prognostication in chronic coronary syndromes
thumbnail
Congress Presentation
Effect of improving utilization of guideline-directed medical therapy for heart failure.

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources